Nuclear Regulatory Commission
The U.S. Nuclear Regulatory Commission (NRC) is proposing to amend its regulations to reduce barriers to medical use licensing. This proposed rule responds to Executive Order 14300, "Ordering the Reform of the Nuclear Regulatory Commission," which requires the NRC to conduct a review and wholesale revision of its regulations. This proposed rule, if adopted, would reduce overly prescriptive regulations, increase flexibility, and modernize radiation safety practices for the medical use of byproduct material. It also would enable more efficient and predictable licensing for emerging medical technologies and reduce unnecessary burden in training and experience requirements for medical authorized users. The NRC is revising guidance for this proposed rule. This proposed rule also would incorporate minor editorial corrections.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Nuclear Regulatory Commission 10 CFR Part 35 [NRC-2025-1237] RIN 3150-AL50 ( printed page 47042) AGENCY: Nuclear Regulatory Commission. ACTION: Proposed rule and guidance; request for comment. SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is proposing to amend its regulations to reduce barriers to medical use licensing. This proposed rule responds to Executive Order 14300 , “Ordering the Reform of the Nuclear Regulatory Commission,” which requires the NRC to conduct a review and wholesale revision of its regulations. This proposed rule, if adopted, would reduce overly prescriptive regulations, increase flexibility, and modernize radiation safety practices for the medical use of byproduct material. It also would enable more efficient and predictable licensing for emerging medical technologies and reduce unnecessary burden in training and experience requirements for medical authorized users. The NRC is revising guidance for this proposed rule. This proposed rule also would incorporate minor editorial corrections. DATES: Comments must be submitted electronically using https://www.regulations.gov by 11:59 p.m. eastern time on September 10, 2026. ADDRESSES: Submit your comments, identified by Docket ID NRC-2025-1237, at https://www.regulations.gov . If your material cannot be submitted using https://www.regulations.gov , call or email the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. Do not includ…
Citation: 91 FR 47042
